Maxim's Maxamine Phase III data

MAXM's first U.S. Phase III study of its Maxamine histamine immune stimulant in combination with IL-2 compared to IL-2 alone hit one of two primary end points,

Read the full 276 word article

How to gain access

Continue reading with a
two-week free trial.